Sound Stimuli: Dr Mai Nguyen, CEO of OptoCeutics shares about 40 Hertz light & sound therapy, research and innovation breakthroughs

Episode 5 November 26, 2025 00:30:45
Sound Stimuli: Dr Mai Nguyen, CEO of OptoCeutics shares about 40 Hertz light & sound therapy, research and innovation breakthroughs
The Dementia Research Project
Sound Stimuli: Dr Mai Nguyen, CEO of OptoCeutics shares about 40 Hertz light & sound therapy, research and innovation breakthroughs

Nov 26 2025 | 00:30:45

/

Show Notes

Dr. Mai Nguyen is a trailblazer in neurotechnology, pioneering advancements in non-invasive light therapy for the treatment of Alzheimer’s and dementia. As CEO and Co-founder of OptoCeutics, Dr. Nguyen leads the charge in bridging the gap between neuroscience and therapeutic innovation, offering new hope to millions affected by cognitive decline.

In this episode, Dr Mai discusses her pioneering work in non-invasive light therapy to combat Alzheimer's and dementia. Learn about her innovative device, EVY, that uses light and sound to improve cognitive function and the exciting potential for broader applications in mental health and preventative care.

Other Episodes

Episode 20

November 01, 2024 00:39:22
Episode Cover

Virtual Reality: Colin Pudsey, CEO of SilVR Adventures explains VR tech in aged care, entrepreneurship philosophy, and impact across APAC

Colin Pudsey is the CEO and Founder of SilVR Adventures, a company that enhances seniors' lives through virtual reality experiences. With a background in...

Listen

Episode 12

August 28, 2024 00:25:23
Episode Cover

Cultural Relevance: Pelden Chejor shares about research into care for older immigrants in Australia, growing up in Bhutan, and dementia research challenges

Pelden Chejor is a public health professional and PhD candidate at Edith Cowan University. His research seeks to explore and analyze the experiences of...

Listen

Episode 4

November 21, 2025 00:30:32
Episode Cover

Blood Diagnostics: Mike Banville, CEO of ALZPath on early dementia detection, accessibility and innovation of blood tests

Mike Banville is CEO of ALZpath; a company on a mission to change how we detect Alzheimer’s, earlier and more accessibly. With a career...

Listen